Healthcare / Healthcare PayersHealthcare Providers

Digital Therapeutics - Ophthalmology

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER

What is Digital Therapeutics - Ophthalmology?

Companies in this market develop digital therapeutics to treat various ophthalmological conditions, such as amblyopia, myopia, and visual impairments from brain injuries. Many of them are developing video games — accessed through mobile apps or virtual reality headsets — that help improve visual acuity.

Selling a product or service?
Reach more buyers.

Your future customers are researching their next tech solution on CB Insights. Make sure they can find you.

Claim your CB Insights Profile

Leaders

Leaders are the most established service providers in the market and possess the breadth to address various customer needs.

See why these companies made it as leaders for Digital Therapeutics - Ophthalmology. These companies include Tilak Healthcare and S-Alpha Therapeutics.

Tilak Healthcare logo
Tilak Healthcare

France / Founded Year: 2016

Tilak Healthcare specializes in digital healthcare and is dedicated to the development of medically-prescribed video games for the monitoring and follow-up of patients suffering from chronic diseases. The company's application targets ophthalmology with macular diseases, which affect a large number of patients in the aging populations of developed countries.

Known Partners

Voluntis, Novartis

Key People

Edouard Gasser, Philip Bouchet, Laurent Herledan

S
S-Alpha Therapeutics

South Korea / Founded Year: 2019

S-Alpha Therapeutics is a digital therapeutics company with platform technologies that enable digital devices to treat different diseases. S-Alpha has a pipeline of products in the areas of ophthalmology, neuropsychiatry, cancer, and immunology.

Highfliers

Highfliers are the most innovative service providers in the market and possess the resources to address evolving customer needs.

See why these companies made it as highfliers for Digital Therapeutics - Ophthalmology. These companies include .

Outperformers

Outperformers are the most specialized service providers in the market and possess the expertise to address unique customer needs.

See why these companies made it as outperformers for Digital Therapeutics - Ophthalmology. These companies include Nunaps.

N
Nunaps

South Korea / Founded Year: 2017

Nunaps is a digital therapeutics company that develops Nunaps Vision, a VR software that treats visual impairment after brain injury.

Key People

DongHo Kang

Challengers

Challengers are the most promising service providers in the market and possess the agility to address emerging customer needs.

See why these companies made it as challengers for Digital Therapeutics - Ophthalmology. These companies include Luminopia.

Luminopia logo
Luminopia

United States / Founded Year: 2015

Luminopia uses virtual reality goggles to correct amblyopia or lazy eye. Its technology also holds the potential to provide a way to detect this condition, which can frequently go undiagnosed.

Key People

Dean Travers, Scott Xiao

What is Digital Therapeutics - Ophthalmology?

Companies in this market develop digital therapeutics to treat various ophthalmological conditions, such as amblyopia, myopia, and visual impairments from brain injuries. Many of them are developing video games — accessed through mobile apps or virtual reality headsets — that help improve visual acuity.

Selling a product or service?
Reach more buyers.

Your future customers are researching their next tech solution on CB Insights. Make sure they can find you.

Claim your CB Insights Profile